Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshifumi Sugatani

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|August 26, 2018
Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone DisorderToshifumi Sugatani
The Journal of Biological Chemistry|November 17, 2004
Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursorsToshifumi Sugatani, Keith A Hruska
Journal of Cellular Biochemistry|December 15, 2012
Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosisToshifumi Sugatani, Keith A Hruska
The Journal of Biological Chemistry|December 9, 2008
Impaired micro-RNA pathways diminish osteoclast differentiation and functionToshifumi Sugatani, Keith A Hruska
The Journal of Biological Chemistry|December 4, 2002
PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motilityToshifumi Sugatani, Ulises Alvarez, Keith A Hruska
Current Opinion in Nephrology and Hypertension|June 8, 2015
Pathophysiology of the chronic kidney disease-mineral bone disorderKeith A Hruska, Michael Seifert, Toshifumi Sugatani
Blood|January 29, 2011
A microRNA expression signature of osteoclastogenesisToshifumi Sugatani, Jean Vacher, Keith A Hruska
Bone|January 26, 2017
The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiologyKeith A Hruska, Toshifumi Sugatani, Olga Agapova, et al.
Kidney International. Supplement|February 25, 2011
Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?Keith Hruska, Suresh Mathew, Richard Lund, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
N-cadherin in osteolineage cells restrains breast cancer cell growth via inhibition of a PI3K-dependent, Tgf-β1-driven feed-forward loopToshifumi Sugatani, Kate Yeo, Marco Campioli, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|August 26, 2018
Systemic Activation of Activin A Signaling Causes Chronic Kidney Disease-Mineral Bone DisorderToshifumi Sugatani
The Journal of Biological Chemistry|November 17, 2004
Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursorsToshifumi Sugatani, Keith A Hruska
Journal of Cellular Biochemistry|December 15, 2012
Down-regulation of miR-21 biogenesis by estrogen action contributes to osteoclastic apoptosisToshifumi Sugatani, Keith A Hruska
The Journal of Biological Chemistry|December 9, 2008
Impaired micro-RNA pathways diminish osteoclast differentiation and functionToshifumi Sugatani, Keith A Hruska
The Journal of Biological Chemistry|December 4, 2002
PTEN regulates RANKL- and osteopontin-stimulated signal transduction during osteoclast differentiation and cell motilityToshifumi Sugatani, Ulises Alvarez, Keith A Hruska
Current Opinion in Nephrology and Hypertension|June 8, 2015
Pathophysiology of the chronic kidney disease-mineral bone disorderKeith A Hruska, Michael Seifert, Toshifumi Sugatani
Blood|January 29, 2011
A microRNA expression signature of osteoclastogenesisToshifumi Sugatani, Jean Vacher, Keith A Hruska
Bone|January 26, 2017
The chronic kidney disease - Mineral bone disorder (CKD-MBD): Advances in pathophysiologyKeith A Hruska, Toshifumi Sugatani, Olga Agapova, et al.
Kidney International. Supplement|February 25, 2011
Cardiovascular risk factors in chronic kidney disease: does phosphate qualify?Keith Hruska, Suresh Mathew, Richard Lund, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
N-cadherin in osteolineage cells restrains breast cancer cell growth via inhibition of a PI3K-dependent, Tgf-β1-driven feed-forward loopToshifumi Sugatani, Kate Yeo, Marco Campioli, et al.
Pageof 3